82 related articles for article (PubMed ID: 25013904)
1. Clinical characteristics and outcome of patients with neuroblastoma presenting genomic amplification of loci other than MYCN.
Guimier A; Ferrand S; Pierron G; Couturier J; Janoueix-Lerosey I; Combaret V; Mosseri V; Thebaud E; Gambart M; Plantaz D; Marabelle A; Coze C; Rialland X; Fasola S; Lapouble E; Fréneaux P; Peuchmaur M; Michon J; Delattre O; Schleiermacher G
PLoS One; 2014; 9(7):e101990. PubMed ID: 25013904
[TBL] [Abstract][Full Text] [Related]
2. Management and outcome of stage 3 neuroblastoma.
Modak S; Kushner BH; LaQuaglia MP; Kramer K; Cheung NK
Eur J Cancer; 2009 Jan; 45(1):90-8. PubMed ID: 18996003
[TBL] [Abstract][Full Text] [Related]
3. MYCN amplification, TERT rearrangements and ATRX mutations in neuroblastoma: clinicopathological correlates- an Indian perspective.
Kerkar AN; Chinnam D; Verma A; Peters NJ; Kakkar N; Trehan A; Singh M; Gupta K
Virchows Arch; 2023 Oct; 483(4):477-486. PubMed ID: 37460674
[TBL] [Abstract][Full Text] [Related]
4. A MYCN-independent mechanism mediating secretome reprogramming and metastasis in
Zhang HF; Delaidelli A; Javed S; Turgu B; Morrison T; Hughes CS; Yang X; Pachva M; Lizardo MM; Singh G; Hoffmann J; Huang YZ; Patel K; Shraim R; Kung SHY; Morin GB; Aparicio S; Martinez D; Maris JM; Bosse KR; Williams KC; Sorensen PH
Sci Adv; 2023 Aug; 9(34):eadg6693. PubMed ID: 37611092
[No Abstract] [Full Text] [Related]
5. Infantile mediastinal neuroblastoma presenting as an oncologic emergency: usefulness of serum-based
Suematsu M; Yagyu S; Hosoi H; Iehara T
BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34972781
[TBL] [Abstract][Full Text] [Related]
6. Posttreatment complications in pediatric cervical neuroblastoma: A retrospective case series at a tertiary cancer center.
Lopez J; Subramanian T; Durell J; Levyn H; Wong R; Shah J; LaQuaglia MP; Gerstle JT
J Surg Oncol; 2024 Feb; 129(2):219-223. PubMed ID: 37850570
[TBL] [Abstract][Full Text] [Related]
7. Super enhancers define regulatory subtypes and cell identity in neuroblastoma.
Gartlgruber M; Sharma AK; Quintero A; Dreidax D; Jansky S; Park YG; Kreth S; Meder J; Doncevic D; Saary P; Toprak UH; Ishaque N; Afanasyeva E; Wecht E; Koster J; Versteeg R; Grünewald TGP; Jones DTW; Pfister SM; Henrich KO; van Nes J; Herrmann C; Westermann F
Nat Cancer; 2021 Jan; 2(1):114-128. PubMed ID: 35121888
[TBL] [Abstract][Full Text] [Related]
8.
Pouliou M; Koutsi MA; Champezou L; Giannopoulou AI; Vatsellas G; Piperi C; Agelopoulos M
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835497
[TBL] [Abstract][Full Text] [Related]
9. Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case Study.
Corallo D; Zanon C; Pantile M; Tonini GP; Zin A; Francescato S; Rossi B; Trevisson E; Pinato C; Monferrer E; Noguera R; Aliño SF; Herrero MJ; Biffi A; Viscardi E; Aveic S
Cells; 2021 Oct; 10(10):. PubMed ID: 34685674
[TBL] [Abstract][Full Text] [Related]
10. Intra-Tumour Genetic Heterogeneity and Prognosis in High-Risk Neuroblastoma.
López-Carrasco A; Berbegall AP; Martín-Vañó S; Blanquer-Maceiras M; Castel V; Navarro S; Noguera R
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680323
[TBL] [Abstract][Full Text] [Related]
11. Visual conservation treatment dilemmas in neuroblastoma with bilateral blindness.
Cheng H; Lin Y; Yang W; Chang X; Feng J; Yang S; Liu S; Yu T; Peng X; Zheng P; Zhang C; Jia H; Qin H; Wang H
Discov Oncol; 2024 Feb; 15(1):48. PubMed ID: 38403682
[TBL] [Abstract][Full Text] [Related]
12. Emergence of new ALK mutations at relapse of neuroblastoma.
Schleiermacher G; Javanmardi N; Bernard V; Leroy Q; Cappo J; Rio Frio T; Pierron G; Lapouble E; Combaret V; Speleman F; de Wilde B; Djos A; Ora I; Hedborg F; Träger C; Holmqvist BM; Abrahamsson J; Peuchmaur M; Michon J; Janoueix-Lerosey I; Kogner P; Delattre O; Martinsson T
J Clin Oncol; 2014 Sep; 32(25):2727-34. PubMed ID: 25071110
[TBL] [Abstract][Full Text] [Related]
13. Bone marrows from neuroblastoma patients: an excellent source for tumor genome analyses.
Abbasi MR; Rifatbegovic F; Brunner C; Ladenstein R; Ambros IM; Ambros PF
Mol Oncol; 2015 Mar; 9(3):545-54. PubMed ID: 25467309
[TBL] [Abstract][Full Text] [Related]
14. Ultra-High Density SNParray in Neuroblastoma Molecular Diagnostics.
Ambros IM; Brunner C; Abbasi R; Frech C; Ambros PF
Front Oncol; 2014; 4():202. PubMed ID: 25161957
[TBL] [Abstract][Full Text] [Related]
15. Recent insights into the biology of neuroblastoma.
Schleiermacher G; Janoueix-Lerosey I; Delattre O
Int J Cancer; 2014 Nov; 135(10):2249-61. PubMed ID: 25124476
[TBL] [Abstract][Full Text] [Related]
16. Targeting chromosome 12q amplification in relapsed glioblastoma: the use of computational biological modeling to identify effective therapy-a case report.
Castro MP; Khanlou N; Fallah A; Pampana A; Alam A; Lala DA; Roy KGG; Amara ARR; Prakash A; Singh D; Behura L; Kumar A; Kapoor S
Ann Transl Med; 2022 Dec; 10(23):1289. PubMed ID: 36618786
[TBL] [Abstract][Full Text] [Related]
17. Identification of recurrent 3q13.31 chromosomal rearrangement indicates
Martinez-Monleon A; Gaarder J; Djos A; Kogner P; Fransson S
Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36601748
[TBL] [Abstract][Full Text] [Related]
18. Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup.
Martinez-Monleon A; Kryh Öberg H; Gaarder J; Berbegall AP; Javanmardi N; Djos A; Ussowicz M; Taschner-Mandl S; Ambros IM; Øra I; Sandstedt B; Beiske K; Ladenstein R; Noguera R; Ambros PF; Gordon Murkes L; Ljungman G; Kogner P; Fransson S; Martinsson T
Sci Rep; 2022 Jul; 12(1):12420. PubMed ID: 35859155
[TBL] [Abstract][Full Text] [Related]
19. High Grade of Amplification of Six Regions on Chromosome 2p in a Neuroblastoma Patient with Very Poor Outcome: The Putative New Oncogene
Ognibene M; Amoroso L; Melchionda F; Cangelosi D; Zara F; Parodi S; Pezzolo A
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830942
[TBL] [Abstract][Full Text] [Related]
20. KDM2B regulates choline kinase expression and neuronal differentiation of neuroblastoma cells.
Domizi P; Malizia F; Chazarreta-Cifre L; Diacovich L; Banchio C
PLoS One; 2019; 14(1):e0210207. PubMed ID: 30629659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
